lobbying_activities: 2159161

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2159161	4ed43446-3f7f-4b90-82fd-e527ac02acc0	Q2	VIZIENT, INC.	40021	VIZIENT INC	2018	second_quarter	TAR	Tariffs - Raised concerns about the impact of proposed tariffs on the cost of prescription drugs and medical supplies.	Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		175000	0	0	2018-07-19T17:40:11.307000-04:00